嗅神经母细胞瘤内镜手术与传统手术联合放疗疗效分析

高炜, 汪银凤, 王亚林, 等. 嗅神经母细胞瘤内镜手术与传统手术联合放疗疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(2): 128-130. doi: 10.13201/j.issn.1001-1781.2020.02.007
引用本文: 高炜, 汪银凤, 王亚林, 等. 嗅神经母细胞瘤内镜手术与传统手术联合放疗疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(2): 128-130. doi: 10.13201/j.issn.1001-1781.2020.02.007
GAO Wei, WANG Yinfeng, WANG Yalin, et al. Analysis of the effect of endoscopic surgery combined with conventional surgery in Neuroblastoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(2): 128-130. doi: 10.13201/j.issn.1001-1781.2020.02.007
Citation: GAO Wei, WANG Yinfeng, WANG Yalin, et al. Analysis of the effect of endoscopic surgery combined with conventional surgery in Neuroblastoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(2): 128-130. doi: 10.13201/j.issn.1001-1781.2020.02.007

嗅神经母细胞瘤内镜手术与传统手术联合放疗疗效分析

  • 基金项目:
    国家自然科学基金项目(No:81800911);安徽省自然科学基金项目(No:1808085MH294)
详细信息

Analysis of the effect of endoscopic surgery combined with conventional surgery in Neuroblastoma

More Information
  • 目的 探讨内镜手术与传统手术联合放射治疗嗅神经母细胞瘤的疗效。方法 回顾分析43例接受手术联合放疗的嗅神经母细胞瘤患者疗效,按照手术方式分为内镜手术与传统手术,所有患者术后均接受放疗,放疗剂量60~70 Gy,对2组患者的5年生存率、局部复发时间进行比较,对比内镜手术与传统手术的治疗效果。结果 通过生存分析,开放手术组与内镜手术组5年总体生存率分别为50%和58%(P=0.560);局部复发率分别为44%与48%(P=0.288),平均复发时间分别为5.6个月与12.5个月(P=0.032)。结论 内镜手术与传统手术联合放疗治疗嗅神经母细胞瘤疗效无差异,且局部复发时间显著延长,在早期嗅神经母细胞瘤患者诊治中,鼻内镜手术治疗效果和患者生存治疗方面可能优于开放手术。
  • 加载中
  • 图 1  嗅神经母细胞瘤内镜手术与传统手术联合放射治疗患者生存率比较

    图 2  嗅神经母细胞瘤内镜手术与传统手术联合放射治疗复发时间

  • [1]

    Palejwala SK, Sharma S, Le CH, et al. Complications of Advanced Kadish Stage Esthesioneuroblastoma: SingleInstitution Experienceand Literature Review[J]. Cureus, 2017, 9: e1245.

    [2]

    Konuthula N, Iloreta A M, Miles B, et al. Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the NationalCancer Database[J]. Head Neck, 2017, 39: 1962-1968. doi: 10.1002/hed.24770

    [3]

    罗宁, 郭汝元. 嗅神经母细胞瘤23例临床分析[J]. 中国药物与临床, 2018, 18(3): 417-419. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201803042.htm

    [4]

    Folbe A, Herzallah I, Duvvuri U, et al. Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study[J]. Am J Rhinol Allergy, 2009, 23: 91-94. doi: 10.2500/ajra.2009.23.3269

    [5]

    孙敬武, 汪银凤, 郭涛, 等. 经鼻内镜切除侵犯前颅底鼻腔恶性肿瘤的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(10): 778-781. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201810015.htm

    [6]

    KöNig M S, Osnes T, Meling T R. Treatment of esthesioneuroblastomas[J]. Neurochirurgie, 2014, 60: 151-157. doi: 10.1016/j.neuchi.2014.03.007

    [7]

    文开学, 高颖, 赵菲. 妊娠28+周并发嗅神经母细胞瘤1例[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(8): 75-76. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201708019.htm

    [8]

    Khosla M, Pecci C, Do A, et al. Esthesioneuroblastoma with widespread distant metastasis: Case report and literature review[J]. Ear Nose Throat J, 2018, 97: E18-E21. doi: 10.1177/014556131809700905

    [9]

    Klironomos G, Gonen L, Au K, et al. Endoscopic management of Esthesioneuroblastoma: Our experience and review of the literature[J]. J Clin Neurosci, 2018, 58: 117-123. doi: 10.1016/j.jocn.2018.09.011

    [10]

    黎高新, 周建波, 肖旭平, 等. 传统手术与鼻内镜辅助手术治疗嗅神经母细胞瘤19例分析[J]. 临床耳鼻咽喉头颈外科杂志, 2008, 22(11): 498-499. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH200811012.htm

    [11]

    Castelnuovo P, Bignami M, Delù G, et al. Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience[J]. Head Neck, 2007, 29: 845-850. doi: 10.1002/hed.20610

    [12]

    Zahedi FD, Gendeh BS, Husain S, et al. Ectopic Esthesioneuroblastoma of the Sphenoclivus: A Rare Entity[J]. Indian J Otolaryngol Head Neck Surg, 2017, 69: 125-129. doi: 10.1007/s12070-016-0978-0

    [13]

    Marinelli JP, Janus JR, Van Gompel JJ, et al. Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis[J]. Head Neck, 2018, 40: 2295-2303. doi: 10.1002/hed.25209

    [14]

    朱歆洁, 陈智斌. 显微外科技术辅助鼻-颅底肿瘤切除的临床体会[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(6): 452-456. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201806013.htm

    [15]

    Zafereo ME, Fakhri S, Prayson R, et al. Esthesioneuroblastoma: 25-year experience at a single institution[J]. Otolaryngol Head Neck Surg, 2008, 138: 452-458. doi: 10.1016/j.otohns.2007.12.038

    [16]

    叶宇东, 邱前辉, 张水兴, 等. 原发鼻腔鼻窦恶性肿瘤内镜术后的长期疗效观察[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(12): 1105-1110. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201512016.htm

    [17]

    Petruzzelli GJ, Howell JB, Pederson A, et al. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence[J]. Am J Otolaryngol, 2015, 36: 547-553. doi: 10.1016/j.amjoto.2015.02.008

    [18]

    Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients[J]. Laryngoscope, 2009, 119: 1412-1416. doi: 10.1002/lary.20280

    [19]

    Yu Y, El-Sayed I H, Mcdermott MW, et al. Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension[J]. Laryngoscope, 2018, 128: 2226-2233. doi: 10.1002/lary.27126

  • 加载中

(2)

计量
  • 文章访问数:  1603
  • PDF下载数:  834
  • 施引文献:  0
出版历程
收稿日期:  2019-01-01
刊出日期:  2020-02-05

目录